Ignite Creation Date:
2025-12-24 @ 5:12 PM
Ignite Modification Date:
2025-12-24 @ 5:12 PM
Study NCT ID:
NCT04103450
Status:
COMPLETED
Last Update Posted:
2024-08-21
First Post:
2019-09-23
Is Possible Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Extension Study of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia
Sponsor:
Urovant Sciences GmbH
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-09-19
Start Date Type:
ACTUAL
Primary Completion Date:
2022-07-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-07-29
Completion Date Type:
ACTUAL
First Submit Date:
2019-09-23
First Submit QC Date:
None
Study First Post Date:
2019-09-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-06-11
Results First Submit QC Date:
None
Results First Post Date:
2024-08-21
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2024-08-21
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2024-07-29
Last Update Post Date:
2024-08-21
Last Update Post Date Type:
ACTUAL